{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:44:45Z","timestamp":1760953485026,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1053\/j.jvca.2008.09.011","type":"journal-article","created":{"date-parts":[[2008,12,4]],"date-time":"2008-12-04T05:02:38Z","timestamp":1228366958000},"page":"679-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Use of Activated Factor VII for Ventricular Septal Defect Closure in a Pediatric Patient With Hemophilia A and a High Titer of Inhibitor"],"prefix":"10.1053","volume":"23","author":[{"given":"Duncan G.","family":"de Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin B.","family":"Peeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor C.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2008.09.011_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1365-2516.2003.00780.x","article-title":"The epidemiology of inhibitors in haemophilia A: A systematic review","volume":"9","author":"Wight","year":"2003","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2008.09.011_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2141.1992.tb06951.x","article-title":"Adjusted dose continuous infusion of factor VIII in patients with haemophilia A","volume":"82","author":"Martinowitz","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.jvca.2008.09.011_bib3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.athoracsur.2004.09.001","article-title":"Heart surgery in infants with hemophilia","volume":"81","author":"Murugan","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2008.09.011_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2516.2003.00781.x","article-title":"Immune tolerance induction in patients with hemophilia A with inhibitors: A systematic review","volume":"9","author":"Wight","year":"2003","journal-title":"Haemophilia"},{"issue":"suppl 1","key":"10.1053\/j.jvca.2008.09.011_bib5","first-page":"S61","article-title":"Activated factor VII activates factors IX and X on the surface of activated platelets: Thoughts on the mechanism of action of high-dose activated factor VII","volume":"9","author":"Hoffman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.jvca.2008.09.011_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2516.2005.01075.x","article-title":"Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: Analysis from the Hemophilia and Thrombosis Research Society Registry","volume":"11","author":"Parameswaran","year":"2005","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2008.09.011_bib7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.athoracsur.2006.10.033","article-title":"Recombinant activated factor VII in cardiac surgery: A systematic review","volume":"83","author":"Warren","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2008.09.011_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","author":"O'Connell","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2008.09.011_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2008.09.011_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.PCC.0000123546.78900.67","article-title":"The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass","volume":"5","author":"Pychynska-Pokorska","year":"2004","journal-title":"Pediatr Crit Care Med"},{"key":"10.1053\/j.jvca.2008.09.011_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1460-9592.2006.02039.x","article-title":"Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage","volume":"16","author":"Brady","year":"2006","journal-title":"Paediatr Anaesth"},{"key":"10.1053\/j.jvca.2008.09.011_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2516.2004.00912.x","article-title":"Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors","volume":"10","author":"Schneiderman","year":"2004","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2008.09.011_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.jvca.2007.09.009","article-title":"Fatal thrombosis after factor VII administration during extracorporeal membrane oxygenation","volume":"22","author":"Swaminathan","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2008.09.011_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1051\/ject\/200638254","article-title":"Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: A case report and brief review","volume":"38","author":"Trowbridge","year":"2006","journal-title":"J Extra Corpor Technol"},{"key":"10.1053\/j.jvca.2008.09.011_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1213\/ane.0b013e31817b7864","article-title":"Thromboelastography-guided factor VIIa therapy in a surgical patient with severe hemophilia and factor VIII inhibitor","volume":"107","author":"Pivalizza","year":"2008","journal-title":"Anesth Analg"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077008002929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077008002929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:34:32Z","timestamp":1760945672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077008002929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1053077008002929"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2008.09.011","relation":{},"ISSN":["1053-0770"],"issn-type":[{"type":"print","value":"1053-0770"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Activated Factor VII for Ventricular Septal Defect Closure in a Pediatric Patient With Hemophilia A and a High Titer of Inhibitor","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2008.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}